Mon, March 11, 2024

Neena Bitritto-Garg Maintained (AMLX) at Strong Buy with Decreased Target to $8 on, Mar 11th, 2024

Neena Bitritto-Garg of Deutsche Bank, Maintained "Amylyx Pharmaceuticals, Inc." (AMLX) at Strong Buy with Decreased Target from $36 to $8 on, Mar 11th, 2024.

Neena has made no other calls on AMLX in the last 4 months.



There are 2 other peers that have a rating on AMLX. Out of the 2 peers that are also analyzing AMLX, 1 agrees with Neena's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Umer Raffat of "Evercore ISI Group" Downgraded from Buy to Hold on, Friday, March 8th, 2024


This is the rating of the analyst that currently disagrees with Neena


  • Graig Suvannavejh of "Mizuho" Reiterated at Strong Buy with Increased Target to $32 on, Friday, March 8th, 2024